Ledger.Open graph →
SEC Form D · Amendment · filed October 25, 2013

Altheus Therapeutics Inc

Offering
$8.2M
Sold
$6.9M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
OKLAHOMA CITY, OK
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (7)

Deborah A. Farrington · NEW YORK, NYExecJohn W. Sinnenberg · CLEVELAND, OHDirectorPhilip S. Curatilo · CLEVELAND, OHExec · DirectorTed R. Laufik · CLEVELAND, OHDirectorW. P. Rond · CLEVELAND, OHDirectorDaniel J. Kessler · CLEVELAND, OHExecBeth H. Laschinger · CLEVELAND, OHDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗